---
title: The role of stem cell transplant (auto and allo) in PTCL and CTCL
date: '2024-12-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39644016/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241208172307&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: In contrast to B-cell lymphoma, the advent of modern targeting drugs
  and immunotherapeutics has not led to major breakthroughs in the treatment of peripheral
  T-cell lymphoma (PTCL) to date. Therefore, both autologous and allogeneic hematopoietic
  cell transplantation (HCT) continue to play a central role in the management of
  PTCL. Focusing on the most common entities (PTCL not otherwise specified, angioimmunoblastic
  T-cell lymphoma, and ALK-negative anaplastic large cell lymphoma), we ...
disable_comments: true
---
In contrast to B-cell lymphoma, the advent of modern targeting drugs and immunotherapeutics has not led to major breakthroughs in the treatment of peripheral T-cell lymphoma (PTCL) to date. Therefore, both autologous and allogeneic hematopoietic cell transplantation (HCT) continue to play a central role in the management of PTCL. Focusing on the most common entities (PTCL not otherwise specified, angioimmunoblastic T-cell lymphoma, and ALK-negative anaplastic large cell lymphoma), we ...